Back to Search Start Over

Abstract 1028: Hypoxia induces Notch signaling and promotes breast cancer metastasis by stimulating growth and self renewal of cancer stem-like cells

Authors :
Keisuke Koeda
Masaki Endo
Sudha K. Pai
Puspa R. Pandey
Aya Kobayashi
Toshimi Chiba
Kounosuke Watabe
Misako Watabe
Masahiro Kashiwaba
Tamotsu Sugai
Kazuyuki Suzuki
Koji Fukuda
Shigeru Hirota
Hiroshi Okuda
Fei Xing
Go Wakabayashi
Wen Liu
Source :
Cancer Research. 71:1028-1028
Publication Year :
2011
Publisher :
American Association for Cancer Research (AACR), 2011.

Abstract

Notch signaling is often and aberrantly activated by hypoxia during tumor progression; however, the exact pathological role of hypoxia-induced Notch signaling in tumor metastasis is as yet poorly understood. In this study, we aimed to define the mechanism of Notch ligand activation by hypoxia in both primary tumor and bone stromal cells in the metastatic niche and to clarify their roles in tumor progression. We have analyzed the expression profiles of various Notch liagnds in 779 breast cancer patients in GEO database and found that the expression of Jagged2 among all five ligands is most significantly correlated with the overall- and metastasis-free survival of breast cancer patients. The results of our immunohistochemical (IHC) analysis for Jagged2 in 61 clinical samples also revealed that both Jagged2 and Notch signaling were strongly up-regulated at the hypoxic invasive front. Activation of Jagged2 by hypoxia in tumor cells induced EMT and also promoted cell survival in vitro. Notably, a γ-secretase inhibitor significantly blocked Notch-mediated invasion and survival under hypoxia by promoting expression of E-cadherin and inhibiting AKT phosphorylation. Importantly, Jagged2 was also found to be up-regulated in bone marrow stroma under hypoxia and promoted the growth of cancer stem-like cells by activating their Notch signaling. Therefore, hypoxia-induced Jagged2 activation in both tumor invasive front and normal bone stroma plays a critical role in tumor progression and metastasis, and Jagged2 is considered to be a valuable prognostic marker and may serve as a novel therapeutic target for metastatic breast cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1028. doi:10.1158/1538-7445.AM2011-1028

Details

ISSN :
15387445 and 00085472
Volume :
71
Database :
OpenAIRE
Journal :
Cancer Research
Accession number :
edsair.doi...........62d311427694a6f8fb26df98de914830